Fei Xiao

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Joachim Lupberger, Mirjam B. Zeisel, Fei Xiao et al. · Nature Medicine · 2011 · 692 citations · Full text

Life Sciences, Infectious Diseases, Molecular Medicine +14

Infectious SARS-CoV-2 in Feces of Patient with Severe COVID-19

Fei Xiao, Jing Sun, Yonghao Xu et al. · Emerging infectious diseases · 2020 · 559 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China

Fang Lei, Ye-Mao Liu, Feng Zhou et al. · Hepatology · 2020 · 448 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι

Yiwen Zhang, Yingshi Chen, Yuzhuang Li et al. · Proceedings of the National Academy of Sciences · 2021 · 445 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +15

Psychological status and behavior changes of the public during the COVID-19 epidemic in China

Xi Liu, Wen-Tao Luo, Ying Li et al. · Infectious Diseases of Poverty · 2020 · 387 citations · Full text

Health Professions, Behavioral Sciences, Psychology +12